METAvivor funds research that specifically addresses the mechanistic understanding, diagnosis, and/or treatment of metastatic breast cancer. All individuals with a clinical doctoral degree or with a doctoral degree who are actively engaged in areas of metastatic breast cancer research and treatment are eligible to apply.
METAvivor Translational Research Award: Up to 3 years, $450,000 award for established investigators.
Application Portal Opens: February 1, 2023
Required Letter of Intent Due: March 11, 2023
Invitations to Submit Full Application Sent: June 2, 2023
Invited Applications Due: August 22, 2023
Announcement of Awardees: December 20, 2023
METAvivor Early Career Investigator Award: Up to 2 years, $200,000 award available to early career applicants (investigators within 10 years of their degree award date and within 6 years of starting their first non-tenured position if started).
Application Portal Opens: January 31, 2023
Required Letter of Intent Due: March 10, 2023
Invitations to Submit Full Application Sent: June 1, 2023
Invited Applications Due: August 21, 2023
Announcement of Awardees: December 20, 2023
METAvivor funds research focused on treating established breast cancer metastases to improve outcomes for stage IV metastatic breast cancer patients. We do not fund research that that seeks to prevent or diagnose breast cancer metastasis, or that is focused on improving quality of life.
Thank you for your interest and participation.
